Does faecal diversion induce clinical response for Crohn's disease of the colorectum?

被引：0
|
作者：
Lightner, A. [1 ]
Buhulaigah, H. [2 ]
Zaghiyan, K. [2 ]
Vaidya, P. [1 ]
Regueiro, M. [1 ]
Fleshner, P. [2 ]
机构：
[1] Cleveland Clin, Dept Colorectal Surg, Cleveland, OH 44106 USA
[2] Cedars Sinai, Colon & Rectal Surg, Cleveland, OH USA
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P514
引用
收藏
页码：S445 / S446
页数：2
相关论文
共 50 条
  • [41] Serologic markers anti-12 and anti-OmpC predict clinical response to fecal diversion in Crohn's disease
    Spivak, J
    Targan, SR
    Fleshner, P
    DISEASES OF THE COLON & RECTUM, 2004, 47 (04) : 602 - 602
  • [42] Mucosal microbial load in Crohn's disease: A potential predictor of response to faecal microbiota transplantation
    Sarrabayrouse, Guillaume
    Landolfi, Stefania
    Pozuelo, Marta
    Willamil, Joseane
    Varela, Encarna
    Clark, Allison
    Campos, David
    Herrea, Claudia
    Santiago, Alba
    Machiels, Kathleen
    Vermeire, Severine
    Marti, Marc
    Espin, Eloy
    Manichanh, Chaysavanh
    EBIOMEDICINE, 2020, 51
  • [43] Response to Biologic Therapy in Crohn's Disease Does Not Differ By Race
    Patil, Seema
    Ghazi, Leyla
    Rustgi, Ankur
    Cross, Raymond
    Flasar, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S471 - S471
  • [44] Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn's Disease
    Galazzo, Gianluca
    Tedjo, Danyta I.
    Wintjens, Dion S. J.
    Savelkoul, Paul H. M.
    Masclee, Ad A. M.
    Bodelier, Alexander G. L.
    Pierik, Marie J.
    Jonkers, Daisy M. A. E.
    Penders, John
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (10): : 1273 - 1282
  • [45] ELEVATED FAECAL CALPROTECTIN PREDICTS DISEASE PROGRESSION IN CROHN'S DISEASE
    Kennedy, N. A.
    Chang, J.
    Guy, M. H.
    Smith, T.
    Loh, J. T.
    Haunschmidt, D.
    Muscat, M.
    Spurio, F. Fasci
    Drummond, H. E.
    Kingstone, K.
    Noble, C. L.
    Shand, A. G.
    Satsangi, J.
    Arnott, I. D.
    Lees, C. W.
    GUT, 2013, 62 : A7 - A7
  • [46] Elevated Faecal Calprotectin Predicts Disease Progression in Crohn's Disease
    Kennedy, Nicholas A.
    Chang, Jeff
    Guy, Miriam
    Smith, Tom
    Loh, Joash T.
    Haunschmidt, David
    Muscat, Martina
    Spurio, Federica Fasci
    Drummond, Hazel E.
    Kingstone, Kathleen
    Noble, Colin
    Shand, Alan G.
    Satsangi, Jack
    Arnott, Ian D.
    Lees, Charlie W.
    GASTROENTEROLOGY, 2013, 144 (05) : S105 - S105
  • [47] Does Smoking Decrease the Response to Infliximab in Patients with Crohn's Disease?
    Parsi, Mansour A.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 : S18 - S19
  • [48] HISTOLOGICAL ACTIVITY IN CROHN'S DISEASE: RELATIONSHIP WITH CLINICAL INDICES, ENDOSCOPIC ACTIVITY AND FAECAL CALPROTECTIN
    Buisson, Anthony
    Mak, Wing Yan
    Andersen, Michael J.
    Lei, Donald
    Pekow, Joel R.
    Cohen, Russell D.
    Pereira, Bruno
    Setia, Namrata
    Weber, Christopher R.
    Hart, John A.
    Rubin, David T.
    GASTROENTEROLOGY, 2018, 154 (06) : S592 - S593
  • [49] Histological activity in Crohn's disease: Relationship with clinical indices, endoscopic activity and faecal calprotectin
    Buisson, A.
    Mak, W. Y.
    Andersen, M. J., Jr.
    Lei, D.
    Pekow, J.
    Cohen, R. D.
    Pereira, B.
    Setia, N.
    Weber, C.
    Hart, J.
    Rubin, D. T.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S179 - S180
  • [50] Clinical response to the canakinumab in crohn’s disease related artrhritis
    Zübeyde Gündüz
    Ruhan Düşünsel
    Duran Aslan
    Betül Sözeri
    Ayşenur Paç Kısaarslan
    Pediatric Rheumatology, 12 (Suppl 1)
12345